Upjohn Inc Uncategorized Contracts & Agreements
14 Contracts & Agreements
- Omnibus Amendment No. 1, effective as of May 17, 2023, by and among Viatris Inc., Biocon Biologics UK Limited, Biosimilar Collaborations Ireland Limited, Biosimilars Newco... (Filed With SEC on August 7, 2023)
- Offer Letter with Scott A. Smith, dated February 24, 2023 (Filed With SEC on February 27, 2023)
- Amendment No. 1 to Transaction Agreement, dated as of November 28, 2022, by and between Biocon Biologics Limited and Viatris Inc (Filed With SEC on November 29, 2022)
- Transaction Agreement, dated as of February 27, 2022, by and among Biocon Biologics Limited and Viatris Inc (Filed With SEC on February 28, 2022)
- Letter Agreement entered into on July 29, 2019 by and between Pfizer Inc. and Michael Goettler (Filed With SEC on March 1, 2021)
- Letter Agreement entered into on June 26, 2019 by and between Pfizer Inc. and Michael Goettler (Filed With SEC on March 1, 2021)
- Letter Agreement entered into on June 25, 2019 by and between Pfizer Inc. and Sanjeev Narula (Filed With SEC on March 1, 2021)
- Letter Agreement entered into on February 6, 2020 by and between Pfizer Inc. and Sanjeev Narula (Filed With SEC on March 1, 2021)
- Description of Viatris Inc. Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 1, 2021)
- Intellectual Property Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)
- Employee Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)
- Tax Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)
- Form of Dealer Agreement among Viatris, Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the dealer thereto (Filed With SEC on November 19, 2020)
- Amendment No. 1, dated as of May 29, 2020, to the Business Combination Agreement, dated as of July 29, 2019, by and among Pfizer Inc., Upjohn Inc., Utah Acquisition Sub Inc.,... (Filed With SEC on June 2, 2020)